- Home
- APLT vs PXS Comparison
APLT vs PXS Comparison
Compare APLT & PXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- PXS
- Stock Information
- Founded
- APLT 2016
- PXS 2015
- Country
- APLT United States
- PXS Greece
- Employees
- APLT N/A
- PXS N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- PXS Marine Transportation
- Sector
- APLT Health Care
- PXS Consumer Discretionary
- Exchange
- APLT Nasdaq
- PXS Nasdaq
- Market Cap
- APLT 37.5M
- PXS 30.9M
- IPO Year
- APLT 2019
- PXS N/A
- Fundamental
- Price
- APLT $0.40
- PXS $3.02
- Analyst Decision
- APLT Buy
- PXS Strong Buy
- Analyst Count
- APLT 7
- PXS 1
- Target Price
- APLT $6.10
- PXS $10.00
- AVG Volume (30 Days)
- APLT 1.9M
- PXS 12.9K
- Earning Date
- APLT 05-20-2025
- PXS 05-20-2025
- Dividend Yield
- APLT N/A
- PXS N/A
- EPS Growth
- APLT N/A
- PXS N/A
- EPS
- APLT N/A
- PXS 0.91
- Revenue
- APLT $455,000.00
- PXS $51,542,000.00
- Revenue This Year
- APLT $1,768.13
- PXS N/A
- Revenue Next Year
- APLT $361.28
- PXS $16.64
- P/E Ratio
- APLT N/A
- PXS $3.23
- Revenue Growth
- APLT N/A
- PXS 13.36
- 52 Week Low
- APLT $0.30
- PXS $2.53
- 52 Week High
- APLT $10.62
- PXS $5.53
- Technical
- Relative Strength Index (RSI)
- APLT 46.92
- PXS 49.11
- Support Level
- APLT $0.39
- PXS $2.88
- Resistance Level
- APLT $0.44
- PXS $3.06
- Average True Range (ATR)
- APLT 0.04
- PXS 0.13
- MACD
- APLT 0.01
- PXS 0.02
- Stochastic Oscillator
- APLT 45.49
- PXS 46.15
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About PXS Pyxis Tankers Inc.
Pyxis Tankers Inc is an international maritime transportation company focused on mid-sized eco-vessels for the product tanker and dry-bulk sectors. It owns a fleet that comprises double-hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Konkar Ormi, Pyxis Lamda, Konkar Venture, Pyxis Karteria, and others. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals. The company operates under two reportable segments, Tanker Vessels, which derive maximum revenue, and Dry-bulk Vessels.